Navigation Links
Zenotech Issues 20 Lakh Shares to Ranbaxy for Rs 20 Cr

Zenotech Laboratories Ltd today said it will issue 20 lakh equity shares to Ranbaxy Laboratories on a preferential basis for Rs 20 crore. //

The board of directors has approved the issue of 20 lakh equity shares of Rs 10 at a price of Rs 100 on a preferential basis to Ranbaxy, subject to shareholders' approval, the company informed the Bombay Stock Exchange.

The board also approved the allotment of shares over 1.11 crore equity shares to the erstwhile shareholders of Credence Pharmaceuticals (50.07 lakh shares) and Hemarus Healthcare (61. 20 lakh equity shares) pursuant to the Scheme of amalgamation entered between Credence and Hemarus Healthcare with the company, it said.

The scheme had been approved by the High Court of Andhra Pradesh at Hyderabad in its order dated May 02, 2006, it added.

The Extra Ordinary General Meeting will be held on August 10 to seek the shareholder's approval for the above proposal.

Zenotech's shares closed at Rs 72, up 1.69 per cent at the BSE.

Source:PTI News
'"/>




Page: 1

Related medicine news :

1. Ranbaxy Signs Agreement With Zenotech For Cancer Drugs
2. Unsatisfactory Grade On Womens Health Issues
3. Who Board To Discuss Asian Tsunami Related Health Issues
4. WHO Issues Caution Against Bird Flu Epidemic
5. FDA Issues Public Health Advisory on Tysabri, a New Drug for MS
6. Sepsis Death Reported With Mifepristone – FDA Issues Warnin
7. High Court Issues Notice To Centre On Smoking Ban In Films
8. JRRD Focuses On Issues Such As Spinal Cord Injury and Prosthetics
9. China Issues New Legislation To Ban Human Organ Trade
10. Court Issues Order NACO On Gay Issue
11. NGOs and Various Groups Come Together To Address the Issues on AIDS
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/27/2016)... SC (PRWEB) , ... May 27, 2016 , ... ... a line of classic American timber frame barn kits, which can be found on ... are inspired by historic American barn plans, and they highlight the craftsmanship of timber ...
(Date:5/27/2016)... ... ... An influential resource amongst nurses and professionals in the health care world, ... of topics detailing why we appreciate nurses in so many different ways. From exclusive ... being in a major recession to one of the hottest growing professions in any ...
(Date:5/27/2016)... ... May 27, 2016 , ... An ... bolstered by inspiring human-interest stories, courtesy of awareness-driven celebrities and thought leaders. It ... leading advocates, associations and industry leaders such as Bioness. , As patients ...
(Date:5/27/2016)... , ... May 27, 2016 , ... ... installment is bolstered by inspiring human interest stories, courtesy of leaders in the ... and tech within the industry, from leading advocates and associations—namely Jones & Bartlett ...
(Date:5/27/2016)... ... May 27, 2016 , ... ... the pharmaceutical, medical and food industries. Aside from its GMP accreditation, Validation Center ... proof of successfully certified products, services and staff. , Validation Center is ISO17025 ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... -- MedDay, a biotechnology company focused on the ... entitled "High doses of biotin in progressive multiple sclerosis: extension ... Professor Ayman Tourbah , Principal Investigator of the Phase ... of Neurology (EAN) in Copenhagen, Denmark . ... place on Sunday, 29 May 2016 from 14:45 to 16:15 ...
(Date:5/24/2016)... 2016 Niederländische Chirurgen haben ... es Ärzten erlaubt, ihre Expertise weltweit zu teilen ... Live Streaming mit einer Instant-Messaging-Funktion und der Möglichkeit, ... in Europa, Afrika, Asien und den ... Plattform registriert. Information und Weiterbildung   ...
(Date:5/24/2016)...   , Study met both ... superiority in , Excellent plus Good ... of the ascending colon   , ... today announced new positive data from the phase III MORA study ... 2 litre PEG with ascorbate. The study met both primary endpoints ...
Breaking Medicine Technology: